Eye Can’t Handle This: Finding Drugs for Ocular Disease

Eye Can’t Handle This: Finding Drugs for Ocular Disease
Event Ended

Café Inquiry is a monthly event taking place at various establishments around town. Join us for fun, casual discussions about science and research taking place right here in Central Indiana. Café Inquiry is hosted by Central Indiana Science Outreach in collaboration with the Center for Inquiry.


Topic:

Many diseases can damage our eyes. Several of these involve abnormal growth of the blood vessels that normally nourish our light-sensing cells. These diseases – such as diabetic retinopathy and macular degeneration – can lead to blindness if untreated. We will use these diseases as a starting point to talk about how the eye works, as well as modern drug discovery with a focus on the eye. Along the way, we will discuss how the eye is structured, why it has blood vessels, what can go wrong, and how we go about searching for leads towards new drugs to fix these (and other) problems. Eye research is worth seeing!


Speaker Bio:

Tim Corson is an associate professor in the Eugene and Marilyn Glick Eye Institute, Department of Ophthalmology at Indiana University School of Medicine, with appointments in the Department of Biochemistry and Molecular Biology and the Department of Pharmacology and Toxicology. He is also a member of the IU Melvin and Bren Simon Cancer Center and Center for Diabetes and Metabolic Diseases. Originally Australian, he completed BSc, MSc and PhD degrees at the University of Toronto, Canada, and undertook a postdoctoral fellowship at Yale University before starting at IUSM in 2010. His laboratory brings chemical biology approaches to bear on problems in ophthalmology, in particular blocking abnormal blood vessel growth in eye diseases like wet age-related macular degeneration, and his group has discovered novel lead therapeutic compounds covered by multiple patent applications. He has authored nearly 50 publications, and in 2016 was named a Watanabe Translational Scholar Award by the Indiana Clinical and Translational Sciences Institute. He enjoys sharing the excitement (and frustrations) of biomedical research, and has spoken to scientific and general audiences on five continents.

All Indianapolis events